Polymer-coated CoFe2O4 nanoassemblies as biocompatible magnetic nanocarriers for anticancer drug delivery
Source abstract
Abstract
In this work, we report the preparation of cobalt ferrite nanoparticles (CFNPs) coated with hydrophilic polymers guar gum, gum arabic and poly (methacrylic acid) as magnetic nanocarriers and study their conjugation with doxorubicin for the drug release under applied magnetic field. The effect of polymer coating on structural properties is studied using Fourier transform infrared spectroscopy and powder X-ray diffractometry (XRD). The XRD analysis revealed that the polymer coating on the as-synthesized CFNPs has no influence on their crystallite size and it remains between 18 nm and 19 nm. The characteristic morphology, topography and the evidences of polymer coating over the CFNPs are investigated using scanning electron microscopy, atomic force microscopy and thermogravimetric analysis, respectively. Vibrating sample magnetometry revealed the ferromagnetic nature of uncoated CFNPs with a significant saturation magnetization ∼77.2 emu g−1. The dynamic light scattering measurements are also performed to determine the size of uncoated and coated CFNPs. UV–Visible spectroscopy demonstrated a profound loading (70–75%) of doxorubicin onto the magnetic nanocarriers and the efficient release of drug in the presence of external applied magnetic field. In vitro cytotoxic studies confirmed the cytocompatibility mode of coated CFNPs against Chinese Hamster Ovary and Huh-7 cell line, while 0.2 mg mL−1 dose of drug-loaded magnetic nanocarriers inhibited the cell viability of Huh-7 up to 60%. These results strongly encourage the utilization of biocompatible magnetic nanocarriers in targeted drug delivery territory.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnetic Properties and Synthesis of Ferrites · Electromagnetic wave absorption materials · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Kanagesan S, Aziz SB, Hashim M, Ismail I, Tamilselvan S, Alitheen NB, Swamy MK, Purna Chandra Rao B (2016) Synthesis, characterization and in vitro evaluation of manganese ferrite (MnFe2O4) nanoparticles for their biocompatibility with murine breast cancer cells (4T1). Molecules 21:31210.3390/molecules21030312 ↗
2. Sheikh A, Jain P (2016) A thorough study of zinc ferrite nanoparticles with reference to green synthesis. Int J Nanomed Nanosurg 2. http://dx.doi.org/10.16966/2470-3206.11510.16966/2470-3206.115 ↗
3. Pardoe H, Clark PR, Pierre TG, Moroz P, Jones SK (2003) A magnetic resonance imaging based method for measurement of tissue iron concentration in liver arterially embolized with ferrimagnetic particles designed for magnetic hyperthermia treatment of tumors. Magn Reson Imaging 21:483–48810.1016/S0730-725X(03)00072-9 ↗
4. Yoza B, Matsumoto M, Matsunaga T (2002) DNA extraction using modified bacterial magnetic particles in the presence of amino silane compound. J Biotechnol 94:217–22410.1016/S0168-1656(01)00427-8 ↗
5. Rudge SR, Kurtz TL, Vessely CR, Catterall LG, Williamson DL (2000) Preparation, characterization, and performance of magnetic iron–carbon composite microparticles for chemotherapy. Biomaterials 21:1411–142010.1016/S0142-9612(00)00006-5 ↗
6. Das M, Mishra D, Maiti TK, Basak A, Pramanik P (2008) Bio-functionalization of magnetite nanoparticles using an aminophosphonic acid coupling agent: new, ultradispersed, iron-oxide folate nanoconjugates for cancer-specific targeting. Nanotechnology 19:41510110.1088/0957-4484/19/41/415101 ↗
7. Chauhan RP, Singh G, Singh S et al (2011) Biotinylated magnetic nanoparticles for pretargeting: synthesis and characterization study. Cancer Nanotechnol 2:111–12010.1007/s12645-011-0021-9 ↗
8. Roullin V-G, Deverre J-R, Lemaire L et al (2002) Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Eur J Pharm Biopharm 53:293–29910.1016/S0939-6411(02)00011-5 ↗
9. Figuerola A, Di Corato R, Manna L, Pellegrino T (2010) From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res 62:126–14310.1016/j.phrs.2009.12.012 ↗
10. Rahal HT, Awad R, Abdel-Gaber AM, Bakeer DES (2017) Synthesis, characterization, and magnetic properties of pure and EDTA-capped NiO nanosized particles. J Nanomater 2017: 7460323-110.1155/2017/7460323 ↗
11. Douziech-Eyrolles L, Marchais H, Hervé K et al (2007) Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles. Int J Nanomed 2:541–550
12. Yu S-T, Chen T-M, Tseng S-Y, Chen Y-H (2007) Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem Biophys Res Commun 358:79–8410.1016/j.bbrc.2007.04.107 ↗
13. Alexiou C, Jurgons R, Schmid R, Hilpert A, Bergemann C, Parak F, Iro H (2005) In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles. J Magn Magn Mater 293:389–39310.1016/j.jmmm.2005.02.036 ↗
14. Jurgons R, Seliger C, Hilpert A, Trahms L, Odenbach S, Alexiou C (2006) Drug loaded magnetic nanoparticles for cancer therapy. J Phys Condens Matter 18:S289310.1088/0953-8984/18/38/S24 ↗
15. Soares PI, Machado D, Laia C, Pereira LC, Coutinho JT, Ferreira IM, Novo CM, Borges JP (2016) Thermal and magnetic properties of chitosan-iron oxide nanoparticles. Carbohydr Polym 149:382–39010.1016/j.carbpol.2016.04.123 ↗
16. Roy I, Stachowiak MK, Bergey EJ (2008) Nonviral gene transfection nanoparticles: function and applications in the brain. Nanomedicine NBM 4:89–9710.1016/j.nano.2008.01.002 ↗
17. Nikalje A (2015) Nanotechnology and its applications in medicine. Med Chem 5:81–8910.4172/2161-0444.1000247 ↗
18. Chouhan R, Bajpai AK (2009) Real time in vitro studies of doxorubicin release from PHEMA nanoparticles. J Nanobiotechnol 7:510.1186/1477-3155-7-5 ↗
19. Maaz K, Mumtaz A, Hasanain SK, Ceylan A (2007) Synthesis and magnetic properties of cobalt ferrite (CoFe2O4) nanoparticles prepared by wet chemical route. J Magn Magn Mater 308:289–29510.1016/j.jmmm.2006.06.003 ↗
20. Tamhankar PM, Kulkarni AM, Watawe SC (2011) Functionalization of cobalt ferrite nanoparticles with alginate coating for biocompatible applications. Mater Sci Appl 02:1317–1321
21. Rana S, Gallo A, Srivastava RS, Misra RDK (2007) On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics. Acta Biomater 3:233–24210.1016/j.actbio.2006.10.006 ↗
22. Eshraghi M, Kameli P (2011) Magnetic properties of CoFe2O4 nanoparticles prepared by thermal treatment of ball-milled precursors. Curr Appl Phys 11:476–48110.1016/j.cap.2010.08.032 ↗
23. Khandekar MS, Kambale RC, Patil JY, Kolekar YD, Suryavanshi SS (2011) Effect of calcination temperature on the structural and electrical properties of cobalt ferrite synthesized by combustion method. J Alloy Compd 509:1861–186510.1016/j.jallcom.2010.10.073 ↗
24. Ullah Z, Atiq S, Naseem S (2013) Influence of Pb doping on structural, electrical and magnetic properties of Sr-hexaferrites. J Alloys Compd 555:263–26710.1016/j.jallcom.2012.12.061 ↗
25. Salunkhe AB, Khot VM, Thorat ND et al (2013) Polyvinyl alcohol functionalized cobalt ferrite nanoparticles for biomedical applications. Appl Surf Sci 264:598–60410.1016/j.apsusc.2012.10.073 ↗
26. Liu G, Hong RY, Guo L, Li YG, Li HZ (2011) Preparation, characterization and MRI application of carboxymethyl dextran coated magnetic nanoparticles. Appl Surf Sci 257:6711–671710.1016/j.apsusc.2011.02.110 ↗
27. Sutka A, Mezinskis G, Pludons A, Lagzdina S (2010) Characterization of sol–gel auto-combustion derived spinel ferrite nano-materials. Power Eng 56:254–259
28. Kooti M, Afshari M (2012) Magnetic cobalt ferrite nanoparticles as an efficient catalyst for oxidation of alkenes. Scientia Iranica 19:1991–199510.1016/j.scient.2012.05.005 ↗
29. Paula IPS, Frederik L, Coro E, Laura CJP, Joana TC, Isabel MMF, Carlos MMN, Joao PMRB (2015) Thermal and magnetic properties of iron oxide colloids: influence of surfactants. Nanotechnology 26:42570410.1088/0957-4484/26/42/425704 ↗
30. Tummala S, Kumar MNS, Prakash A (2015) Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer. Saudi Pharm J 23:308–31410.1016/j.jsps.2014.11.010 ↗
31. Lay CL, Liu HQ, Tan HR, Liu Y (2010) Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graftcarbon nanotubes for potent cancer therapeutics. Nanotechnology 21:06510110.1088/0957-4484/21/6/065101 ↗
32. Soares PI, Sousa AI, Ferreira IM, Novo CM, Borges JP (2016) Towards the development of multifunctional chitosan-based iron oxide nanoparticles: optimization and modelling of doxorubicin release. Carbohydr Polym 153:212–22110.1016/j.carbpol.2016.07.109 ↗
33. Box VGS (2007) The intercalation of DNA double helices with doxorubicin and nagalomycin. J Mol Graph Modell 26:14–1910.1016/j.jmgm.2006.09.005 ↗